Subon Co., Ltd. held an exclusive sales agreement ceremony with Pharmtre Co., Ltd. ahead of the launch of the new product esteau Compact Plasma Hydrogen Mist. From the left: Kwon Oh-cheol, Executive Director of Subon; Kim Man-geun, President of Subon; Oh Kyung-hee, Chairman of Subon; Lee Kang-dong, CEO of Pharmtre; Lee Hye-kyung, Vice President of Pharmtre; Lee Jun, Manager of Subon.
Farmtre Co., Ltd. (CEO Kangdong Lee) and Subon Co., Ltd. (CEO Kyunghui Oh), a global leading company in hydrogen water development that first obtained a COVID-19 inactivation test certificate in the industry, held an official exclusive sales agreement ceremony on August 10, 2020, ahead of the production launch of the newly developed ultrasonic hydrogen mist, esteau Compact Plasma Hydrogen Mist.
This product follows Subon's well-known celebrity mist, the esteau tower-type mist. The esteau Compact Plasma Hydrogen Mist, with its sophisticated design and enhanced performance, will begin official sales from September 15 through Farmtre's supply chain (in charge: Vice President Hyekyung Lee) not only in Korea but also across overseas markets including China.
A company representative explained, “The esteau Compact Plasma Hydrogen Mist, which improves the performance of enhanced hydrogen water, helps with pore contraction and wrinkle improvement through natural hydrogen nanobubbles, collagen production, whitening, and moisturizing, along with skin sterilization effects. It is a functional product named ‘esteau Compact’ that is conveniently portable due to its hand-held size.”
Meanwhile, ‘esteau’ is a French portmanteau meaning ‘beautiful water,’ symbolizing ‘beauty and health’ protected by water.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
